JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 71 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,782 | +63.7% | 2,585 | 0.0% | 0.00% | – |
| Q4 2022 | $2,921 | -51.3% | 2,585 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -14.3% | 2,585 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -61.1% | 2,585 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $18,000 | -18.2% | 2,585 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $22,000 | +15.8% | 2,585 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $19,000 | +5.6% | 2,585 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $18,000 | +38.5% | 2,585 | +109.7% | 0.00% | – |
| Q1 2021 | $13,000 | +44.4% | 1,233 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | -10.0% | 1,233 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | +11.1% | 1,233 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 1,233 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -45.5% | 1,233 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | +175.0% | 1,233 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -33.3% | 1,233 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | -25.0% | 1,233 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | +100.0% | 1,233 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -50.0% | 1,233 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | -11.1% | 1,233 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | -67.9% | 1,233 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $28,000 | +75.0% | 1,233 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | +60.0% | 1,233 | +98.9% | 0.00% | – |
| Q3 2017 | $10,000 | +11.1% | 620 | 0.0% | 0.00% | – |
| Q2 2017 | $9,000 | -35.7% | 620 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $14,000 | – | 620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |